Average Co-Inventor Count = 5.31
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (7 from 2,405 patents)
2. Lawrence Livermore National Security, LLC (3 from 1,571 patents)
3. Trius Therapeutics, Inc. (2 from 8 patents)
9 patents:
1. 10858360 - Tricyclic gyrase inhibitors
2. 10442829 - Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
3. 10385055 - Tricyclic gyrase inhibitors
4. 10065947 - Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
5. 9988406 - Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
6. 9732083 - Tricyclic gyrase inhibitors
7. 9624250 - Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
8. 8604209 - Methods for preparing oxazolidinones and compositions containing them
9. 8426389 - Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate